Is The Tesla Run Over?

Episode Summary:

Why Cannabis Stocks Are Trading HigherElon Musk takes a shot at Bernie Sanders$QSR Restaraunt Brands purchases Firehouse Subs

Guests:

Matt Hammond, IPO Warriors 10:00

https://www.Ipowarriors.com

Twitter: https://twitter.com/warrioripo

Cybin CYBN CEO Doug Drysdale 48:00

Jake Wujastyk, Co-Founder, TrendSpider 62:00

Twitter: https://twitter.com/Trendspider_J

https://www.trendspider.com Enter promo code BZ25 to get 25%

Chris Capre  https://2ndskiesforex.com/ 93:00

Hosts:

Spencer Israel

Twitter: https://twitter.com/sjisrael

Aaaron Bry

Twitter: https://twitter.com/aaronbry5

Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptions

Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.

Unedited Transcript

Happy Monday, everybody, the markets are back open. Let us know in the chat. What y'all are watching and trading today. A B here, Spencer with me as always Spencer, how are we doing today?

We're doing well. We're doing well. Uh, how do we want on the new intro? I saw I saw a new intro. I think it, I think it's, it's part of the way there. I don't think it's all the way there. Do you want to run with the, uh, part of the way there and new intro, the old intro, or just roll? Why don't we roll? No intro today.

Let's just rolling. No intro. This is the show it is starting actually already has started. So

my question may be is what has taken a bigger haircut? My head or my portfolio? I don't know. I mean, hopefully your, your portfolio is not taking too big of a haircut. Considering cannabis stocks are all up nicely today. They are, um, using some of my handy-dandy metrics out of the top five trending tickers on social media.

So Reddit, Twitter, all the whole investing sphere, two out of the top five trending stocks are in the cannabis space. Spend six. Guess what those two stocks are. Okay. Okay. Without looking two of the top five trending, trending on social media stocks today, um, Uh, are they both stocks? Are any of them? ETS?

Are they both? Stocks is one of them kind of be growth? Nope. Damn. Okay. Oh, for one is one of them Grogan. Nope. One for two. Okay. Is one of them, are they both? Are they OTC? No. Uh huh. A Tilray would be the third, the third guest. So Ray's one of them. I see the other one in the chat sundial. Yep. Tiller and sundial are two of the top five trending tickers.

Uh, the non-cannabis stocks in that top five are Tesla, Nvidia and Vivian. Okay. So, um, we're, we're going to talk about all this today. Let's talk about everything so that, you know, Tilray and the rest of the cannabis stocks are up on the news that the Republicans are bringing forth a bill to legalize cannabis in the United States.

Um, Spencer, do you know anything more about that bill? Uh, another due to present it today, uh, I got to give the, give it to the Republicans. They just basically just hijacked and one of the key issues on the democratic platform and said, well, we'll take that. Thank you very much. Yeah. They're basically saying, Hey, if you guys aren't going to do this, we will and we'll get the credit for it because it's one of those measures that's widely popular throughout the, um, you know, all voters in the United States.

So it's, it's. You know, one of those things that'll be a good, easy political win for the Republican so we can get it through which we will see. Um, but either way, I mean, even if they don't, because then if the Democrats step in and have problems with the bill and they can say, oh, Hey look, it's the Democrats holding up, um, you know, legalizing cannabis, which again is something that's, that's very popular.

Um, solar up saying, yeah, they, they want to legalize the profits, but we'll see. I mean, I assume there will be, you know, we'll see if, if there can be bipartisan, um, support and work done on the bill. I'm not very bullish on that. We should probably save this discussion for later on, on this show, because we're going to have a cannabis related CEO, uh, on Doug Drysdale was a CEO of Simon to your CYB N related to cannabis, uh, kind of right.

Tangentially. It's the same idea of legalizing a drug. It's the same idea, uh, surviving, um, psychedelics are a few years behind cannabis. Um, in everything, right? In terms of regulatory changes, legalization and capital markets a few years on cannabis. So, um, I would be curious to get Doug's thoughts on all this, but I, that being said, speaking of guests, uh, we skipped it on here.

Cause our first guest will be on here joining in, in a minute or so. Um, Matt Hamon from IPO warriors is going to recap, uh, last week in IPO lane and preview what is to come this week in IPO's. I'd be curious to hear how Matt played a reveal. And last week I mentioned our Drysdale, uh, from Simon. That'll be at 1245.

Love Jake, would you ask Dick from transporter on the show one and Chris Capri from seconds guys trading on the show at one 30. So do as a favor, hit that like button, tell your friends, tell your neighbors, tell your friends, neighbors, dog. And, uh, we can get ourselves off to a good show today. Good start to the week.

So like you said, markets in the green, at least last I checked I'm in the green. You're in the green row on the green. What about Dylan? What about Igor? What about bear for one of the chats? I actually took a little thump ski it's in the red right now, but it looks like it's coming back up. I don't know.

Yeah, I know it dropped about a quarter for cent out of nowhere at around 11:40 AM Eastern. So that's interesting that 20 minutes ago, I know we'll keep an eye on that. Uh, Q Q kind of same thing, but yeah, Spencer, so big headline over the weekend was of course, Elon Musk on Twitter, uh, you know, took a shot at Bernie Sanders, which some people love.

Some people didn't love. Uh, but, but overall, the, the bigger story here is just Tesla's price action in the last week. Um, the stock let's pull up a chart so we can wait, I'll pull my, while you talk, this stock is down more than 15% in the last week. So we're used to seeing Tesla stock, you know, take rips up.

Of course, nothing goes straight up. There will be dips along the way, but usually with Tesla, those are followed by bigger rips. The question is, will we get that bigger rip or what will we see the weakness continue? And Tesla's chart. What is test on a bear market? Is that what this is? Where, uh, let me, I'm going on a different chart here by standard definition of going down 20% or more, um, from its all time highs yesterday in a bear market.

Oh my God. Yeah. I mean, we, like I said, we will see, cause a lot of times these dips are followed by bigger rips. And that will be the question with Tesla stock. I think this week will be very, very important to see, um, who knows by the end of the week, we could be back at all time highs at around 1200 or we could come all the way back down to 800.

So anyone out there that's trading Tesla, let me know how you are trading it in the chat. I'm very curious, you know, are you, are you playing it with the options? Are you buying the stock? Are you buying the dip? Um, let us know what you think about Tesla, because right now it just seems like there's a lot of wins being taken out of the sale.

Of course, Elon Musk has a lot of different reasons to sell stock. Part of it is that if he doesn't sell any now than a lot of his options can expire, um, without him exercising them because you can only exercise so many each quarter. So if he doesn't start doing it now, um, he literally needs money to pay the taxes, right.

And, and like, and she doesn't have the money they're there. They're the adage goes, there are a bunch of reasons to sell a stock, um, paying taxes, being one of them. There are only a few reasons to buy one reason to buy. There's only one reason. One reason to buy. Well, yeah, we'll say there's only one reason buy what's the other reason using the one, one reason why talking to.

Well, if you're like a inset. Yeah. But if you're say short a stock, you need to buy it to cover. You know, there, there are multiple reasons you can buy something. If you're an insider, like Elon Musk is, and you're going to buy the stock. There really is only one reason because you think it's going higher.

There are a multitude of reasons is why you would want to sell a stock. But I think regardless of what that reason is for Elan, um, for Tesla, shareholders and Tesla fans in general, seen him sell stock is a bear sign. So we shall see. But right now, Tesla down about 4% on the day, continuing, uh, uh, bear trend for the stock, which we haven't said in a while.

So, um, again, let us know in the chat, how you guys are trading it. Um, etc. Same Tesla just approved to sell electricity and sexist. We'll see if that can be a catalyst for the stock, but who knows, Dave is saying he's buying the dip every time it's on sale. So it has been proven right? Time and time again, buying the dip always works.

Isn't that the rule, it always works except in some stocks. Yep. So Spencer, before we get to Matt Hammond, we've got one more headline, this one in the restaurant space. Um, so if you're a, you know, a fan of fast food chains, whatever this may interest you, uh, QSR. Yeah. We know it. Owners of burger king and Timmy hoes over owners of burger king, Tim Horton's, Popeye's just acquired another brand today and an all cash deal, a sandwich.

Franchise, you know which one that is Spencer? I, well, I saw the headline, it was firehouse subs. It was $5, billion dollars for firehouse. So some expensive subs. So that just goes to show you guys, if you open a sub shop and you do well and you franchise it out a little bit, you can sell it for a billion dollars.

A restaurant brands goes out, buys, firehouse, and then a $1 billion cash meal, uh, you know, will, it looks like the markets like the move for QSR up about a percent, but nothing crazy. So we will see how prior house is able to impact, uh, restaurant brands is, you know, revenue, balance sheet overall, but just some, just some headlines in the restaurant space.

That is, that is a, those are some expensive stuff. That's all I'll say by Shelly, congrats to the firehouse subs, seriously, that company donates a portion of their profits to firehouses. So, so congrats to them. Great job. Yeah. Who knows? Maybe they'll stop that. Now that they're under new ownership. I doubt it.

I hope not. Um, Shelly pointed out another headline in the, in the restaurant, fast food space. So McDonald's announced a partnership is still relevant. It's about to be holiday season. So every time Mariah Carey she's and it's here, it's here. It makes it come back every year around Christmas time. So we've seen, McDonald's do this with a few other artists have, have, you know, deals.

They have one with BTS the popular, uh, K-pop Korean pop band. They have one with Travis Scott. Um, so now they're doing the same with Mariah K. Yeah, I know. So anyway, uh, so we know it's approaching Mariah Carey's season. Uh that's that's in a couple of weeks though. Uh, you know what season is now? It's Manhattan season.

It's IPO season. Let's get mad at him and all the total talks to my POS. Is he at? Nah. Hey, I'm doing great. How are you guys doing it is IPO season. Um, we had an off season there and, uh, some, some pretty big ones. So, uh, okay, excellent. I can't wait to hear how you put revealed last week. So here you go. I told you I was going to watch for Vivian, but it did play out what we'll get to that one in a second.

Um, first thing I wanted to say is thanks to everybody who contributed to the fundraising campaign. I said, I wanted to get some better streaming equipment. I want to live stream. Some IPOs have been talking with Benzinga they've at least indicated. Maybe we'll do a little bit more switching out to watching some of these actually go live.

I think it would have been pretty fun to watch some of what ribbon did, uh, you guys have, you know, talking to Rowan, he's going to kick me out some gear as well. Uh, but we, uh, we got $2,000 in under one week. Um, and I really appreciate all the support. Some of the things I'm gonna use that for is improving the presentation quality of these, uh, kind of weekly shows.

I would like to do some live streaming of the IPO debuts. And if time allows, I will do some video breakdowns of the IPO as before, uh, before they go live. Um, really appreciate that. It's not too late to contribute more, I'll buy more stuff and, um, you know, improve things even better. You should have some equipment on the way, man.

Yes. So I've heard and I, and I'll ask for some, if you guys have some t-shirts or stuff, I'll wear those on the, on the show and with what I'm doing. So, you know, uh, yeah. Yeah. Well say what's on your waist. Some schwag sweats. Okay. So we actually had a lot of really good ones. Um, we talked about sent a one off 25%.

We'll just run through these real quick. I didn't like this as a play. I don't generally like, uh, anything that dumps like that anyway, uh, dumped off the debut. If you did say, Hey, wait, this is below the IPO price. It's dip this far. How, you know, how bad could it get? Um, you know, you were rewarded not just with a retracement up to , which is a lot of times all that we see.

Um, but if you held through that and said, okay, well, I'll give this some room to run. Uh, it just for no real reason blew up, uh, head up to 2250. And you know, one of the things about trading is you're looking for, uh, stocks with catalysts. You're looking for volatility. That's what you're looking for in day trading.

And that's why I like IPO is not, all of them are going to do this. Uh, but if you have, if you like this company, I guess a lot of people do like this company, um, you know, your catalyst is, Hey, it's IP. Uh, the momentum, the volatility, the volume are all going to be about as high as you can ask for on the days that they IPO, which is what make these attractive targets for a day traders.

So St was one society pass. If you remember last week, I said, Hey, this kind of, you know, a crappy, uh, Asian e-commerce ish, you know, S IPO that really looks sort of weird with a pretty low float. This could be a stealth IPO. Um, I tried to get in on this, and unfortunately we will hit the indication price rate before it debuted.

So I had mindset at 1350 and it debuted at 1550 and then dropped to 15. So if I had been a little bit more aggressive out of caught this ride from 15 through four halts, top tier, like 42 or something, um, came back here around 30 and we see these just run the same pattern, ran up to 52. Uh, the next morning ran up to 70 and we saw these with thanks.

Uh, C pop, um, TRS. Why do you suppose that is? I don't know if we've ever, if I've ever acted that before. Yeah. So there's different theories about this. Um, Having talked about it with a bunch of people and putting our heads together. The thing that makes the most sense to me is that, you know, whoever's buying it way up here is not trying to buy low and sell high.

They're almost like trying to buy high and sell low, um, or really just buy high and not give a crap. I was going to say, buy high and sell higher. I thought, well, I mean, who's buying, I mean, they are pushing this up through halts on day two, you know, and somebody paid somebody up at $60 for a garbage company.

I mean, we saw EJH was one of them that did this and it's like a cleaning company in China. Uh, w and w which spiked yesterday through some Holtz off some random, I mean, they're, they're low float to begin with. They tend to try to do things to deter us from seeing them or for wanting to play them.

They're so bad that, um, you know, no one in their right mind is going to pay this thing. The IPO price was a $99, you know, who is going to say, okay, well, this company has no revenue or barely any revenues. The, uh, the, the platforms that they run are garbage. Uh they're they're just losing money. You know, who's going to pay $15.

It's so bad that it's good. It's so bad. That it's good. That's what I think. I know. I mean, my, my answer and for this until proven otherwise is that they're all, they all have ties to China. I mean, we saw FCU. The was a uplifting. They all have a similar on underwriters. This one was max. We've seen a lot of them that were, uh, boasted securities.

We saw a bunch that were network one financial Sutter, and a lot of these companies have done IPOs together. They've co-written, um, you know, been the co-writers on IPOs as the underwriters. So there's sort of like, they must happen my theory and they use the same lawyers and they have, uh, my opinion is that they're helping Chinese and other wealthy Asians, especially Chinese follow money out of China.

So if you have a whole bunch of money in a bank account in China, and you're trying to get it into Hong Kong or Singapore or into the Western markets, what you can do is you can issue shares somehow out to, you know, if you can hand shares cheaply to your cousin or your uncle or some affiliated partner outside of China then, and just tell them, Hey, I will control the, you know, control it, just control the float.

And I will buy, you know, as much of this stuff as I can, uh, with this say $200 million I have in a bank account here in China, you know, that money as I buy those shares that no one else has no. You know, who else is participating in this market? Not a lot of people. So if I'm the only one buying your shares, I'm basically giving you that money and moving that money from China to, um, you know, to the west.

And I talked about last week, pets, pets was one that I had called out a month ago and sent out to my newsletter when it was about a dollar 30 or a dollar for. Because they had the same underwriter do a direct offering of 30 million shares basically at about 60 or came out to about 30 cents a share when you factored out the warrants and the profits.

And you're like, well, that should just sink the share price, but it didn't, it did a little bit, um, but it came right back up and now it's up at $6. You know, it was at $4 when we talked about it on the show last week. So why are they doing this? Why is hoodie H UDI? Why has that got to $45 in the last, you know, few months?

Why has, why did TRX go all the way up to a hundred dollars? And then in one day lost 90% of its value with, you know, with no headline, no new news, no nothing. Um, why does, uh, w and w sometimes randomly pop, why do, uh, you know, why do these go well? Because in my opinion, they're moving money. They're using these as vehicles to get money out of Asia and into, you know, Western markets and the seat after, after this happened, I went back and said, geez, you know, Y you know, what, what did I miss here to not make me just put my limit order at like 16 or 20 for that matter?

And I went back and I looked up, the CEO is, you know, extensive experience doing startups in Shanghai. The CFO, you know, is Chinese. So, um, you know, there are hands FCU V when we look back at it, we said, oh, we had our eye on it. And it took a day before they ran it from like five or $6, all the way to 25. Uh, in one day after their up listing, and then now it's come way back down, but what was up there?

Oh, the whole, like the only three employees are all very, very Chinese as in, they don't even have American alias names. They're Chinese engineers. So this tie back to China, and that makes sense if you're a wealthy Chinese person with tons of money in China right now, given what, you know, president Xi is doing over there, he is basically cracking down on the wealthy and if I was a rich person, uh, or a rich person in China, more specifically, I would be trying to get my money out of there too.

And it's not easy to do that. So even if you're paying a 30, 20, or 30% premium on the shares that maybe get bought out or sold by other people, um, and this is an effective way to, and it's not the first time that the stock market has been used as a way to funnel cash out of a country. The Russians were doing this in the nineties.

Um, and that's, that's the only answer that I have. How does, you know, how do completely garbage companies make insane runs? Uh, that all of a sudden, I mean, this one's still kind of holding on, but I don't, it's, it's, it's nowhere near any reasonable valuation and all of these tend to Peter out, or they all do Peter out eventually.

And when I look at pets and what they're doing there, I'm just like, okay, I'll just, I sold enough. You know, I bought in at basically a dollar 20 and I sold enough when I reached eight on one of these days where it gets by. That I've already paid for my position. And now I can just sit back and if they run it, I think they're still running it because it hasn't fallen out yet.

And when it does fair enough, fair enough. Anyway, I try to call these out when I I've made huge profits on some of these, uh, I made 30,000, $33,000 on a thousand shares of TRX. When it debuted, it went opened at 17, went into a three-hour hall and opened up again at $50. You know, so if you can spot these and you take kind of a, okay, well, you know, I'll, I'll give it a shot approach to it.

I mean, the, the returns have been massive. UTME that was another one. Anyway, back to the more traditional kind of fun and boring ones that are also profitable. If you play them right. Expensify, we said we liked, uh, we got in here at the debut. I do like taking a $2 profit rate off the run. Um, it's sort of, kind of the easiest, I would say two hours and trading is defined a good, you know, a good company with these guys had to have a positive baseline financials.

They're somewhat brand recognized the float wasn't too big and it gave you exactly what you expected right off the debut. So you buy a thousand shares, get in it, you know, say 39 75, sell it at 42. That's like a really pretty comfortable, easy 5% win, uh, right off the bat. Uh, the market. Wasn't really rewarding.

These IPO's on day one, the way that we've seen maybe three or four weeks ago. So this one pulled back a bit. You could try to double dip. I generally don't do that. Uh, but where the real money was in these plays and I'm taking notes for kind of the next set of, uh, of IPOs is a, these day two runs. Uh, this one actually touched $50 today.

You talked about that a lot. So especially for brand name IPO's, a lot of people are starting to kind of come into the IPO. I'd say that the number of followers I've got has been much higher over the last two weeks than the, you know, the previous six months. And I think a lot of people are keying in on it and it's, in some ways you have to adjust because if everybody's buying in pre debut, that's less demand once it actually goes live.

But a lot of people are kind of catching that overnight media cycle where the, you know, the headlines say, you know, Expensify pops 50% on its debut, and they're not talking about this move. They're talking about the IPO price was like 18, and then it debuted at I. Yeah, I, and you know it, wherever you can do the same thing.

I I'm hoping we can get to that because I, I was taken aback at the ferociousness of the day to run in green river. And I guess I shouldn't have been, but I was cause. Because it seemed to go straight down, skip through the, to that one that, or, you know, black ways, again, $2 taker just right on the debut, $2 in your out hole, you know, and you can hold these and they come back in.

I wanted to show you one thing about holding IPOs. And again, I don't consider playing a debut to be super risky is, um, okay. People who played this cocoa water, uh, you guys were talking about it this morning and that was a, it was actually not a good debut play. Uh, and which is why, you know, when people ask me, oh, what do you think of this company?

I'll say, well, you know, for a long-term position, I don't, I wouldn't suggest buying debut. Um, but you do want to start watching it then, because then you kind of know where it's ranges, where it trends. But if he did say, oh no, this one's going to do great. Uh, everyone loves it. Uh, I'm gonna, I'm going to buy the debut and you got stuck in it and you didn't get any kind of day to run.

I've held IPO debuts for, you know, usually it's about a month before you're gonna see what it's going to turn around or not. And the catalyst you're looking for after the debut is the end of the media. Um, or the, uh, press release kind of silence, period. I guess they call it. And the first earnings report.

Now, these guys happen to come in with a very strong earnings report. And if you had liked this company enough to buy the debut and you have the conviction to buy it there, why not hold it here? See what it does. And. You know, today you finally gotten, you know, today was the first day after a month, basically a trading that you got an opportunity to take your profits.

Do you stop there? Probably I do. If I'm holding a bag and I'm given the opportunity to cut it for a non loss, I'm out, um, very rarely will I hold longer than a day to have it come back and then say, no, I'm going to get greedy. Uh, that's only hurt me when I've tried to be pigs, get slaughtered anyway, a vaccine city by the halt, uh, by the debut, this had a ton of buzz, low float, sell the halt right there.

Easy as pie and take your profits. Say thank you. Uh, derm debut below. Where did I put ribbon? Okay. I would love your thoughts here. Cause it seemed like he just went straight down and I, and I want to pull it up on, um, give me a second. I'll pull it up and we can look at the, uh, the chart here. So ravines pretty much exactly what I said.

It would do two things. One, I had just taken a win on a. What was it? The, uh, Backblaze or the one before that was earlier in the day and after take a win off and just be like, okay, that's the one I wanted. I am, you know, I can try to keep playing more, but I ended up starting to make bad decisions and, uh, try to control against that.

Uh, Ratheon was on one hand, a great a, you know, I mean, how much more social media buzz and momentum could you ask for than any V play when Tesla just broke a thousand and it had a lot of other great, uh, you know, I had a lot of good storylines to it. The Amazon deal it's Ford as an investor, um, but had a huge float and I don't like huge floats the floats 153 million shares.

And we S I think I said on the show that it reminded me a bit of snowflake and Coinbase. And my, and my, uh, theory was that we'd get about 10, 15 minutes of upward momentum and then correction, which is exactly what we saw. And for me, I'm not long EVs. I still think that, you know, at some point in the not so distant future, the market is going to realize that selling vehicles is only so profitable that not everybody, um, is just going to buy one model.

And, uh, you know, they got supply chain issues. It's just the valuations on these don't line up with what automobiles have traditionally sold for. And I think eventually we see that I don't know when it's going to happen. Clearly it wasn't this week. Um, w I did, you know, so I was in the gym and I was watching, you know, ticker in between sets.

And when I saw it kind of come here, I think I'd got off my run and it was a hundred. I thought I already missed that dip here, but, you know, maybe that's the, maybe that's the place to buy for the day to media run, because this is clearly going to get a ton of media hype. And then it started moving down again.

And I kind of said, um, maybe, you know, maybe it's not as hard as I thought it was, but clearly if you saw this and bought in for the day too, and I mean, you're in an excellent position. It's a one, I mean, Clayton has pointed out. I, I, I, I lost sight of it. Yeah. I mean, w w w we did, we hit one 50. Yeah, we did.

We hit one 50. Holy cow. Holy moly. So if I had pulled that day, you know, that day one trigger down here, I would have sold it, maybe one 20. Anyway, I just don't like I went through over the weekend. I went through and I really needed to do a bit of a self evaluation of Metro. And I make so much more on IPO and sort of like, you know, I like to stack guys like Mitch, uh, and the, you know, the blanking on his name there, the guy that does the, the selection.

I mentioned Chris. So they have, I mean, the, the, the, the amount of money that they've made for traders in their spec, like the spec catalyst to me, is kind of similar to the IPO. It's like, you know, what's coming up, you know, that it's going to have a merger vote, you know, that it's going to DCE back and become, you know, a name and that's going to be immediate, you know, the next door.

That was pretty obvious media catalyst. And I went from like 11 to 18 in one day. Uh, so these, you know, I like specs and IPO's because no, where, you know, it's so easy to time what's going to happen with everything else in FDA announcement, that's going to come off market. Or, you know, whoever gets the news first is going to get it.

And some, a spike right up, you know, you don't know that that's coming or these other plays. And I looked back and I just I've done so well on these words, swing trades, where you're trying to find the bottom and, you know, read the trend and you have to wait, you know, a long time to make your money.

Whereas an IPO, I want to make money in like one or two days at keep my, you know, my money in cash. You know, the market can crash one day and I'm not exposed. And I'm just in a, to me, it's it fits my style. Uh, if you can't sit there and play these in real time, would your screen all day, you know, then it's not a great trade.

If you're good at day trading and reading charts and all that stuff, you know, maybe that's better for you. I'm not. Uh, I ended up, you know, with a long list of bags, waiting for them to turn around. I like to get in, get out, hold for one or two days, maybe three, if I really think it's hot and maybe I should have read this one a little bit more.

It's also, is it a price where it could come down a lot more as well? So, um, never been great with EVs, but we'll see this week, there's a lesson to take forward from this week that maybe we will, uh, be able to catch. So, um, let's, uh, jump through affinity. I think we've recovered, uh, covered those. So this week's featured IPOs.

Do you want to say anything more about ribbon? No. I was just curious to hear how you played it. I mean, I sorta lost sight of it today, so I was surprised to see it at one 50. I realistic. I felt like going in, we were, we were Jones in for, for a rock pole on the way that was wrong. That was wrong. Uh, but it just sorta had those vibes near, but Hey, sometimes the obvious place to play.

So, uh, what do we have this week? Ooh, she was asking me when I became a speck fan. Uh, the first fact that I really banked money on was, um, what was that? Uh, Nicola. So I've been in SPAC since pretty much the second one. That was it. That was the second big one of this. Yeah, that was yeah. After fan do. And I got FanDuel like the day after it disrespect or not FanDuel or DraftKings drafting.

So I got, I got dressed and that was like, I didn't really know what a SPAC was. And I think a lot of his back was that in, in may of 2020, so that put them on the maps, put us up, put us on the map. And since then I've played a TMC Michonne. Uh Chris's you know, uh, I got high on cue. I got, uh, they're they're, they're a handful they've been, they've been pretty good.

Uh, and it just, you know, don't get greedy, take your profits and, uh, you know, look for the next one. I'm actually almost always sell out, but by the time I see, you know, 20 to 30% up, I'm just like, yeah. So thanks, bye. You know, and, uh, raise up the cash. And then they run up to like a hundred percent gainers, but that's okay.

My room, I have two rules and trading. They are, uh, written here. So I don't forget. They are take like you can't read them, take profits without regret. And don't chase. Those are my two rules. As long as I stick to those, every time I break those and get myself in trouble, when I stick to those rules to do pretty well.

You got the calendar. I saw one, the other jumped out to me, but so, so let's run through the boring ones. Sure. Uh, sonar group is not so boring when you consider solar coding for. And they do have, this has sexy all over it. Yeah. And they have, so they don't have any revenues, no point in going over financials, they do have 50 million in customer deposits for their sign-on vehicle.

Um, as I understand, those are deposits that, uh, I don't know what the refundability is on those, but when you combine two hot, you know, you're talking about eco solar and Evy and that's, you know, how, how much more do you want there? Right. And you can't put Bitcoin in it's can you, um, so not, yes. Yeah. Right.

But you can buy with Bitcoin. That would be the next catalyst. Um, but, uh, yeah. Uh, they, if they mined Bitcoin with the spare solar power, then maybe you could, you could pump this up even more than it is, but this is about as much, um, kind of hype buzzwords. You can cram into something right now. And I got to try this one because, you know,

yeah, Wednesday, we don't have any until Wednesday kind of a little bit thinner week. This week, Iris energy. This is a Bitcoin miner. Uh, they don't hold Bitcoin on its balance sheets apparently. But if Bitcoin, how is that possible? Uh, maybe they just sell it right away. I'll on mine and they sell it. Okay.

That's something new. I gotta, I gotta research a little bit more, but they do have positive cashflow and operating profit, which leads me to believe that they are selling these, um, And they're basically they're using IPO money to buy more hardware. So if they're successful in mining, why not scale up? Uh, especially when the price of Bitcoin, at least a lot of people believe it's headed to, um, you know, to a hundred thousand.

So if the, unless Bitcoin crashes before Wednesday, uh, this looks like a pretty hot play. S D I G, and a couple of the other, all the other Bitcoin IPOs have done pretty well. So 8.27 million shares. That's pretty low float. I like this. Uh, you know, the trend is your friend Bitcoins are trending. So we got my point, right.

With all these IPO's. So we've got Wednesday, Thursday, Friday. None of them have priced yet. Right. Do we have an expected w we have the ranges, but we don't have the pricing until, and the pricing can change, especially for the hot ones can change dramatically. Can you give the range on these if you have them?

Okay. For, I don't know, they might've pulled as C S E V already. That's too bad. Let me see a Sono price range. 14 to 16. Okay. Um, we've got, uh, IRN 25 to 20. So for the hot ones, we often see them get bumped by, you know, a dollar or two price out of range, a price at the high end and things start pricing at the low end then, unless, you know, if you get a discount to that then, okay.

Maybe that's interesting. Uh, in other words, the debut comes live below the IPO price. That's been a pretty safe, uh, play, as it works its way back up to the IPO price, you would expect not a lot of IPO price, uh, buyers are selling, uh, for an immediate loss. So, um, but kind of pricing in the middle that has not been a very good, a sign of strength and I'm generally sitting on the sidelines for those.

Okay. Um, but yeah, I mean, solar, Evie, and Bitcoin to lead off the schedule, those, you know, once they should be fun, uh, user testing, this is a platform for companies to test user engagement processes. Uh, maybe it's a good business revenues up 44% last nine months gross profit up 51%. Um, but negative cashflow, negative operating loss, negative income.

This is kind of just one of those SAS plays where I've never heard of this company before. It reminds me a little bit of this company was like internet advertising program IAP or something. I don't know the. If you, if there's no brand recognition, they have to be really strong to get, you know, people to come in and buy them.

And there's also a sort of odd follow on offering lurking in the, this is not the, it's not a lock of expiration, but they have the right to sell an additional 27 million shares. If the price is 10% above the IPO price, you know, it's something like over 10 days in the previous week or something like that, the point is that the debut price will likely be over 10% to begin with.

So if the IPO price on this is, uh, 15 to 17, let's say they debut at 17 or 18, and then it actually debuts at 20. So if they IPO price at 17 or 18 and debut at 20, you already at that 10% level, and then it's, it's think it's a hundred days or something 90 days, then they can, you know, then they can sell them 27 additional shares, which almost doubled, you know, it's more than doubles the float.

And I don't really like it when I see those kinds of things just gives me shivers, like remembering what coping had hidden in its, uh, lockup period, which was probably the worst IPO I can recall. Um, playing that was the day was you'd have like 60 or 65 and miss now at 27 and never even gave you like a.

Courtesy rebounded any point, really? It just was a downward downward dumpster fires. Alright, super interesting here. Um, res, now this one is, I mean, a similar customer engagement and communication. Revenue's up 2.6% gross profits up 60% again, negative baselines. And unfortunately it comps to Weaver, which last week did not do well on its debut and brace has a higher valuation, but I think it might appeal to more businesses.

So I don't know, 8 million shares. It's just, I don't feel super good about these. And given that there are others that I do like more this week, I probably just let these pass. I can't play every single IPO. There are people who have that approach, you know, for them and they really manage those trades.

They're better at day trading than I am. They buy on the dip and just hold it for ever sometimes. But, uh, this one to me, both of these sort of user cutting and Braves, both in customer engagement, if user testing, somehow those, well, maybe that changes my opinion on Brays, but I'm looking forward more to this one.

It's a sweet garden. Now we talked before about how restaurant chains have done really well on their IPO's. And I kind of include bros in that, uh, you know, in that group because it's a chain. It does well on. You know, on a limited number of locations, the theory being well, if you raise a bunch of money and expand it nationwide, it'll do even better.

So this one is like, kind of, I guess they say plant forward, which I read as vegetarian, but I guess they probably have some meat in there somewhere. Maybe they do. I'm a little bit deeper. I'm not a vegetarian, but Hey, you know, everybody wants to go out to eat how they want to. But, uh, interestingly, they acquired this company called spice food and this company looks pretty interesting.

They're basically like a robotic powered restaurant system. So you're kind of getting a technology angle on a restaurant chain and given what bros did given what Portillo's did even, uh, F w R G, which is some, you know, breakfast restaurant that I'd never heard of a chain has done, you know, did well off of its date, IPO debut.

So these guys are article last week that robot sales like industrial robot sales are at an all time high. I didn't see that. And that, and that kind of makes me feel like this is in alignment with some of the trending topics in the market right now. Okay. So the rebounding out of COVID revenues up 50%, I mean the revenue numbers mean nothing.

We've talked about this before. If you're going to compare how a restaurant did for any P you know, the last six months, nine months, 39 weeks, whatever, uh, to the year before we're still making comparisons to. And I just kind of have to throw those out the window, uh, negative cashflow, net income, and operating loss.

I don't love though to see that in a restaurant industry, others have been, I think a, you know, Portillo's was, you know, positive and its financials. Um, but I said, I don't want, I'm not going to miss the next chain restaurant play and, uh, bros, Portillo and F WRG. They all did well for IPO's it's 12.5 million shares.

It's got healthiness to it. It's got the sort of, and although, you know, Oatley did badly today and beyond meat hasn't done well, there is still a demand for in health forward plant forward eating. And I want to give a, you know, I want to give a restaurant chain, um, you know, I'm going to stick with the trend there and try the rest of the rest.

Ha ha healthy food. Alternate is not hot right now though. So, well then maybe we get a reasonable entry price on this as well. All right. That's the glass half full approach. Okay. Fair enough. KinderCare. Yeah, the main thing is just again, so KinderCare learning, um, education centers, blah blah, blah, 1500 locations reopening momentum.

They make revenue. This is something this should not be allowed to be a public company. I'm sorry, just to not, no, no. Forget to forget that this should not be a for profit. Like childcare in the, in the U S is so unaffordable. And now we have companies that are going to be publicly traded. They have to answer to investors and the answer to wall street about their stock price and their, their margins and their, and China just made that move a few months ago and killed all the private.

This should not, I, this I, that might not be a popular opinion, but I mean, this should not be a publicly traded company. I missed we're talking about childcare, whatever. Just tell us, tell us about the IPO. Ah, yeah. W gross profits are up 3534%, but again, we're talking about comps to lock down, so I can't count much in there.

They do have positive baseline financials. So cashflow income operating profit are all positive. So it's a big company. I mean, you're talking about 1500 locations and I mean, we're a capitalist society. If our social different socialistic approach to working, you know, the private market's gonna, you know, is the only, it's our only hope of we can otherwise we're just gonna have, you know, who's going to be the educated future.

I mean, I agree with you. I th but we're talking about the holistic approach. We have the socialistic approach to K through 12. It's just pre-K that people versus this is ages six to 12. So this competes with, um, with public school. Okay. Yeah, I do six to 12. I think it's a lot of like preschool and afterschool.

I kind of skipped over because I just sort of like, nah, maybe this company is pissing me off next change the subject. All right. Six weeks to 12 years old. Oh, six a week. Wait. Okay. Whatever I, I w oh yeah. Yeah. We've been filling a need there. I have an 18 month year old kid and a child. And, you know, there are days when we would like to just put her in someone else's care if we found someone trustworthy.

I bet. All right. Um, no, I love my daughter. I love spending time with her, but it's a lot better. Anyway, uh, Austin gold, this one is sort of like, Hmm, well maybe, uh, it's a gold exploration company in Nevada with corporate offices in Vancouver. Uh, they are revenue, which means they basically just are exploring right now.

And the website is horribly lacking. Uh, it looks like something a kind of intern might build as a test project and a web development company. And for me, that's a red flag. I, uh, you know, I mean there's pages where it says like, uh, error content missing on their press releases. Uh, their investor page is basically blank.

Um, and since I am a designer developer, I do find that, especially for these sort of low float under the radar IPO's unless I'm looking for it to be terrible. Uh, not having a strong, solid website is sort of like, I don't know how seriously I can take this company if, um, you know, if they don't even have an updated website, uh, I want to I'm with you.

One interesting thing though, is that, uh, some people I know who have some knowledge of Nevada and gold mining said that these guys are operating before areas that they're operating in are the right areas to be operating in. Um, and the CEO just last week sold his previous company for $2.8 billion, which was it's really M resources.

And he sold it at a, something like a 30, 40% premium to the share price. So Cheryl, you know, shareholders are happy with that. Uh, the float is 3 million shares, but Roth capital is not a particularly loved underwriter. Uh, they must've done something. I still haven't nailed it down, but they have sort of a reputation for screwing, uh, IPO buyers and people tend to avoid them.

Um, we've also seen a lot of their, IPO's just seem to get terminally rescheduled and we're up against the clock. We, we, we got, oh, that low. We're on time. Yes. Awesome. That Hammond runs IPO warriors joins us every Monday to run through the weeks late an IPO. And we appreciate that Matt, or as a pleasure and go to the newsletter.

I get the newsletter. I feel warriors.com. I'm going to start adding some more, uh, kind of featured breakdowns on individual IPOs. Um, my kind of longer-term vision is to have time to make videos, to put on there as well, to break down some of these with a little bit more in-depth analysis of the actual financials, uh, when I'm reading on Twitter, that kind of thing.

So, uh, stay tuned, sign up for the newsletter. Follow me on Twitter. Thanks guys. Have a good week. All right, let's keep it going here. Our next guest has been waiting patiently backstage dog Drysdale. I've mentioned him at the top of the show. He was the CEO of Sayven ticker. CYB N a B. It's bringing him on the show.

How are we doing Doug? Happy Monday. Thank you for taking time out of your day to join us here on Benzinga live. How are you doing today? I'm doing great. Thanks gentlemen. Thanks for having me today. You're welcome. So real quick, before we get started for some of our audience that may not be familiar, do you mind just giving us a quick rundown of what it is that Simon does and what the mission is there?

Yeah. So Simon is a biopharmaceutical company and we're working to transform psychedelic drugs that we've known about for decades now into actual therapeutics for mental health disorders, like depression, addiction, and anxiety disorders. Got it. So last week, I know we saw some news about M C Y B 0 0 3.

So that's one of your guys's PR proprietary drugs. Do you mind just overviewing that news real quick? Yeah. Last week was actually an historic week, uh, in the many decades that people have been working on trying to transform these molecules into actual therapeutics. Two pieces of data came available. One was from one of our peers that for the first time in a 200 plus patients study unequivocally proving that siliciden, which is the active ingredient that comes originally from magic mushrooms, proving that it works in depression and they're paid in helping treat people, people with depression, both the solid and robust resolve at the same time.

Simon released data showing that finally after decades, we're able to completely transform this molecule and turn it into something that's actually useless as a therapeutic. The downside visceral assignment historically has been that clinic times are eight hours. So your patients are in the clinic for eight hours a day.

And significant side effects and adverse events and would see why B3 we've shown that we can cut this clinic time in half and we can reduce potential for side effects like nausea and headache and other adverse events in half as well. So a major breakthrough. So essentially you're saying that so psilocybin on its own, which, which, like you mentioned, is, um, what's found in magic mushrooms has been proven to help with depression, but there've been downsides, um, to just take an oral.

So psilocybin, so with CYB three, you were able to kind of address some of those downsides, um, to, to the actual psilocybin. Exactly. So we've taken psilocybin, we've made it synthetically in the lab and then we've modified it to improve the profile so that it's has a safer profile for patients and pay spend half the time in the clinic.

Got it. So, so for some people out there that may have, um, some of these psychological disorder, major depression disorder, um, bipolar, and I know some of them have, have tried a lot of different things and, um, you know, different medicines on the market don't work. So, so is this something that, uh, can be seen as an alternative to helping these patients when those other medicines don't seem effective?

Yeah. And once approved they have. So when you look historically back at how we treat depression, we typically use drugs called SSRS, which unlike Prozac. And when you look back over the last couple of decades, on average, a SSRI is typically I know better than placebo in patients with mild to moderate depression and many patients try two or three or more of those Sri's before running out of options.

And so a CYB three now provides once it's approved another option for patients to tackle their depression and addiction and anxiety disorder. Did Doug, this has Spencer here. I want to ask you, um, about the, the headline we got late last week, and we're getting again here today about just through the Republican, a bill to legalize cannabis.

Uh, I sort of grew up these two things together. I know they're not really technically the same thing, but I sort of look at, um, psychedelics as, as sort of following the cannabis lead in every respect in terms of just regulation and capital markets. Um, I'm wondering if, if, if the move by, by the GOP, if that has sort of changed your, um, changed the, the, the equation at all for a psychedelic regulation at large in the U S.

No, not really quite different. So I see that there's a general sentiment change towards looking at these alternative types of treatments and that's all positive. We're looking at drug development that needs to go through the FDA and we're planning studies plan that are coming up in early, early next year.

Um, FDA has granted breakthrough therapy status to sub assignment. So they've indicated that this molecule was really potentially important in mental health and da just, uh, came out and said that manufacturers should be making more of these substances to allow more research to be done. So I think we're seeing very positive signs, but DEA and FDA, when it comes to turning these molecules into actual therapeutics that can be prescribed by a physician.

So, so Doug is there, uh, you know, a lot of opposition from, I guess, you know, what you could call like big pharma, some of the producers of these SSRS that see, uh, this field as maybe something that's emerging as a competitor to them. So are there, are they, do you see that opposition for big pharma? No. I think the big pharma will see this as an opportunity.

When you look across the big pharma space, many of their psychic psychiatry departments have gone over the years. They've become neurology departments. And so there's really been very little innovation in psychiatry in maybe 30 years. So when you look at the total addressable market of all these indications that psychedelic companies are working towards, it's around $300 billion annually.

So I think the big pharma will absolutely be interested in this is a space where there's been very little innovation for separately. So Doug for Simon. I mean, I, you know, the namesake comes from psilocybin and mushrooms, but I understand that you're working on other drugs as well. Which other, uh, you know, drugs are you working with outside of psilocybin?

Yes. We're working on some other molecules that are related. Uh, these molecules are called tryptamines, which are all like serotonin, which is a naturally occurring. You're a transmitter in your brain. As we're working on some other tryptamines for anxiety disorders. We're also working on a range of molecules called phenethyl means.

And these are molecules that are related to MGMA or masculine that might help with PTSD in the future. So we have about 50 molecules in our library currently, and we're taking our lead two candidates into the clinic very shortly. Wow. So, so for investors, you know, our, our, our audience here is mostly retail investors some day traders.

What could they be looking out for just in the end, not with cyber in particularly, but just in the industry as a whole, like, are we so early stage that maybe, um, you know, we continue to see some of these names get beaten down or do you think it'll be pretty quickly once we start seeing, okay. People are really noticing that, Hey, look in the psychedelic space, this has actual value and potential, and we can see those investors start coming.

Yeah, there has been a bit of a rush over the last couple of years, companies rushing into this space. Uh, but I think we're moving from a period of news to a period of Qaeda. So Simon was one of the first companies sort of the state of this last week. And I think those data points will start to really separate companies from each other and differentiate them.

So look out for data. That's coming out of clinical studies over the next six to 12 months, and that'll reset some of these companies apart, I think from some earliest stage organizations that are not quite up to speed yet. Good question here from our chat. Um, how does the FDA's new designation for, for a Simon's work, uh, affect the timeline for commercialization?

This is from solar up. Yeah, potentially the breakthrough therapy status, uh, could accelerate the timeline to, to commercialization. There's two things really, uh, the first is that, uh, FDA provides a rolling review. And that just means that they're looking at the data that you submit in real time, not, not in lumps at certain time points, and that's much more efficient.

You also get to collaborate with that day and ask questions, which means that instead of guessing what they're looking for, you can take advice on what they're looking for. And typically we breakthrough therapy status to FDA requires perhaps just one phase three study, which are the big expensive studies rather than two.

So that can save time and cost of coming to market as well. Got it. So do you have any like ballpark timeline on when you hope to get some of these drugs through the pipeline that the approval? Yeah, so unfortunately drug development is quite slow. Um, but for a reason, the good regaining payments have to be, have to be safe and they have to be tested well so that they can be prescribed for patients.

So from where we are today, we're looking at those kind of four to five-year timeframe, still to get through those major critical studies with the first one kicking off in early 20, 22. And then from Brando, likewise, with cannabis or as well as what happened to cannabis, do you foresee it being a case of we get a medical first and recreation and then, and then later on some states doing both at the same time, or, yeah, I don't think so.

These are very much going down the pharmaceutical route. And the concept here is that they will be given under supervision or clinical setting and combined with psychotherapy. So patients will go through a period of therapy associated with the treatment, and it seems to be the combination of psychotherapy and the molecule of the drug itself that lead to these good outcomes.

Uh, in some studies we've seen that four times, the effect size of SSRI is a four times greater effective at treating depression when combining the psychotherapy, uh, with the molecule. So it's hard to see with this current generation of molecules, uh, that there'll be a recreational. Okay, that makes sense.

So, Doug, have you seen a big shift over the last couple of years, just in sentiment regarding, uh, some of these drugs becoming, you know, uh, like viable treatments, because I'm sure, you know, five years ago there would be doctors that scoffed and said, oh, this isn't real medicine, et cetera, but now it seems like more and more people are taking this field seriously.

And it's not just doctors. I mean, first of all, psychiatrists are typically fairly open-minded about trying new treatments for their patients, but then you add in the FDA and the DEA throwing their support behind this work. And then also major chip biotech funds. Many of which have invested in Simon are really getting behind this as well.

And when you start to see the smart money getting into the space and we know that there's real potential. Got it. So I think one of the, you mentioned that in the last 30 years there hasn't been that much, uh, you know, development or improvement in psychiatric care. Um, and I think one of the problems is that a lot of doctors, you know, see it as, okay, I'm going to prescribe someone, uh, you know, this SSRI and that should help alleviate the symptoms or help solve the problem.

But, um, you know, oftentimes a lot of psychiatrists talk about some more holistic measures on top of the medicine. Uh you know, looking at some of these other holistic, you know, things people can do to improve their mental health outside of the drug, or is it simply, um, you're just trying to develop this molecule that you think will be a better.

Well, it sounds for the molecule. Let's make sure that these molecules are, have realistic duration that can be scalable and let's make sure they're safe and well tolerated. So we minimize the side effects, but you also want to make sure given the nature of these molecules that they're given in a safe environment.

So we've created a psychotherapy program called embark. It takes in six domains of best practice, like a therapy. And we using that to train therapists that will apply to therapy in our clinical trials. And we're making that open source. So therapists can get trained. They want to do that, but also to make sure that we're applying it's like therapy in a consistent way and putting patients in a safe environment.

Yeah. I was just curious if that was part of the, I guess quote unquote treatment plan is like, okay, we'll, we'll get, um, this patient on say C Y C Y B3, but that patient should also be getting, I don't know, X amount of hours of sleep a week or exercise, you know, having the other things that help factor into someone's mental health outside of just what drugs they're taking.

Yeah, of course. I mean, exercise, eating well, getting good sleep are all good contributors to mental health. When we look back at some of the academic studies that have been performed using psychedelic drugs, uh, those that have reduced or eliminated the psychotherapy have been shown to be less effective.

So really does seem to be a combination of the psychotherapy and the drug together. So it forms a kind of a package that helps people overcome the trauma. That's underlying that depression, all. So Doug, what drew you to this industry? I mean, do you have more of a psychiatric background or more of a chemistry background?

You know, how did you get here? Yeah, I started out my career in a lab, uh, but I've been in, in, uh, pharmaceuticals in the healthcare industry for 30 years. So I've been developing drugs for, for that time. And, uh, you know, like most of us, you guys too, I'm sure we all know someone in a loved one, family, friends has been affected by depression or addiction.

It's tragic as soon as it's all around us. So in 30 years of drug development, I don't think I've had an opportunity in that time to help as many people in such a profound way as we can with the psychedelics. So, so our mission to really turn these into therapeutics once and for all. So, but do you have anything that drew you particularly to psychedelics or was it just that you identified that, Hey, this is a good opportunity here to maybe help tackle some of these problems once and for all the truly groundbreaking.

I mean, I can set, I have family and friends have been deeply impacted by this and to be able to combine your work with helping the people that you love is never a bad thing. And it's red, you see data like we see with psychedelics and how profound the effect can be. Literally patients who have spent years of addiction walking away from a psychedelic session and free from those addictive cravings for weeks or months at a time from just one session.

I not seen anything like that in my career. So this is an enormous. Got it. Well, Doug, thank you for coming on the show today, we will have to get you back on as Sabin announces more data and news. Um, I know a lot of us here at Benzinga are kind of, you know, following this industry closely and very fascinated by the, um, you know, the progress that has been made so far.

Uh, so Doug, thank you again for coming on. Thanks for having me guys. Um, all right. It's one. O'clock we're going to have our next guest on, in his second before I bring them on, though. Uh, AB did you see what Luminari is doing today? L a Z R L a Z R. We had them on the show on Friday and we're up 11% today.

Let's go. I'm not saying Benzinga is why Luminari is up 11% today, but I'm also not saying ending is not why. Yeah. I've heard some kids on the street are calling the Benzinga bump. Um, oh, I thought that's something different.

I got both errands to live for that one. Oh man. All right. Well, I, I don't even know how to follow that up, so I'm just gonna bring my man Jake on the stream. Jake, how we doing? Hey, how are ya? Thanks for asking what's up. Jake? Who Jasick from trend spider. Jake. I thought of you this morning because we're talking about Grogan and I know that's one of your favorites.

So I'm sure you're happy today. I do like it. Yeah. Now I have it as a long-term investment. It's not something I actively trade, so I just keep dollar cost averaging in, but yeah, definitely a nice day kind of a weird market out there. Honestly, got a lot of, uh, what I like to call Christmas colors in the watchlist.

You don't really have, you know, a lot of green, a lot of red, it's just kind of just every other stock I have in the watch list is either red or green. So getting the Christmas color vibe there right now, but definitely kind of weird with, with spy is a weekly candle from last week. That's something that does have me a little cautious.

I do kind of lighten, lighten some of my positions today. It was a definitely a huge week for me last week in the trading arena. So I definitely don't want to be giving back profits. So, um, I did lighten things up. I still, I think marijuana is probably just getting started, but you know, uh, we have to kind of look at the broad markets before we look at individual names too much.

And, and yeah, so with, with spy, I'd really want to, to get above last, week's hide for this to be a little bit of a more risk on sentiment, but Bitcoin is, well, you have this weird pump last night, and now all of a sudden you're back to where we started. So just kind of a weird market. It is OPEX this week.

So that's something to keep in mind. Uh, Yeah. So that's, yeah, I'm not in any options positions this week, uh, for that reason, just you, you have some crazy moves and, uh, you know, for me, I'm just, I'm just in some common stock positions, but yeah, Bitcoin is the main thing that I'm kind of keeping an eye on here with, uh, with definitely, uh, some rejection and Bitcoin is honestly probably more of a risk on risk off sentiment indicator than even like IWM, IWM used to be my go-to and now it's really Bitcoin.

The fact that we're about to break 60 4k here and getting rejected at these previous highs is, is definitely worth noting. Um, so we'll, we'll have to see what happens, but I, I definitely am a little more cautious than I think I probably would have been, uh, last week. I'm not used to hearing this out of you, Jake.

Yeah, I know. I'm, I'm generally pretty bullish because the charts have been bullish and, and I, I do think that the markets, you know, overall, still look good. I mean, IWM, if you look at IWM on the daily chart, at least we still have the Sr flip. Uh, so that's simply just meaning previous resistance became supportive.

But all in all, uh, you know, just, just based on, Bitcoin's kind of weird price action today, I am a little cautious and, you know, some people may say, well, what does Bitcoin have to do with the broad markets? It's, it's actually a very good, uh, way to gauge, you know, overall liquidity in the market. So anytime you see Bitcoin selling off, it's always worth noting.

Um, so, so yeah know, like you said, I usually am not too cautious with the markets when they're showing strength, but I am a little, especially with it being OPEX week options expiration week, uh, which for some people who are not familiar with OPEX, it's just when a monthly expirations, uh, occur. So, so yeah, I'm, I'm a little cautious.

I definitely have, uh, raised quite a bit of cash, but I do have some open positions. Um, so CGC that's one that I do have an open position on. And you know, the main reason is, is simply because we're just pretty much retesting this previous resistance for now. So you've got this area always is going to be a zone with me.

I don't have an exact trend line that we're going to be looking at for a balance. You've got this zone. And then if we, if we just kind of highlight this area here, uh, highlighted by these green areas, technically we're just retesting that right now. So nothing that I'm too worried about right now. I mean, if you look at the weekly cannon.

Yeah, this is, this was a pretty big, a pretty big reversal here on the weekly. And you can see that we had a very similar candle when we, when we reversed back in March of 20, 20 around COVID and we did have this type of candle. So that's true. And then, and, um, what's the other one there? I can't even really tell it till when, uh, so just to the left.

Yeah. That, yeah, that guy too. So, you know, there's this natural reflex when you see a big, big, uh, green candle, like the one we just got to say, oh, but it's already come so far so fast. But if you look at the previous times, we've got candles that big, you know, that that was the start of something that was a movement.

I don't know if it was moving or not, but it was a start of a trend change in trend. Yeah. I mean, if you look at the, the daily, this is the main thing I'm looking at is a, this long-term trend of that kind of, uh, finally broke to the upside. So if you draw, where did I have that drawing? Of course I don't have it on the chart now.

I don't think I used this one. B it was just a little too. Um, where did I draw it? Well, even here, I mean, you can see that we technically, depending on where you draw the trend line need to still break out a little bit. But, uh, the main thing that I think I had was here, I did use the, uh, the WIC here, so I just drew it kind of here.

And if you look. All we did was we just kinda retested the previous, uh, resistance last week bounced off of it. Now the main level is horizontal a price action. So before it was diagonal that I was looking at now it's more of this horizontal level that I'm kind of keeping an eye on and definitely still have a position, just not as heavy, uh, because at least for me, if the broad markets are showing any signs of possible caution, I'm not going to be heavy in individual names because sure.

Some individual names will do well, but overall, a majority of them will have trouble playing out as these individual setups. If you do have the market kind of being a little weird. So, um, CGC is definitely one that I'm keeping my eye on. A lot of people are, are kind of looking at the US-based stocks right now.

The bigger move for me personally, I liked GRW G because it's not an OTC. Uh, that's why I'm not a huge fan of some of these U S names yet because they're OTC. You don't have as much liquidity don't have as much volume. And, um, you know, I just really, don't like a F five letter a tickers either. So I'm just getting, but, uh, I definitely, haven't gotten too deep into the, you know, the TC in, in apps and all of those just because they are still OTC that may change in the future.

If, if things go well with this, uh, potential federal legalization, but for now, you know, my proxy would be G RWG to play and you can see even this is having a little trouble getting past those previous highs from last week. So, um, all in all, this is one that I have longterm. It's not something that I, uh, you know, I really actively trade.

It's just something that I've kind of bought and will continue to hold on to. Can I, can I offer you another proxy now, full disclosure? This thing has already run up a bit here, but yup. Yup. That's that's the other one too. That's uh, and, and this is the time to start at least paying attention to the monthly candles.

I mean, we still have half of a month left, but, uh, generally you want to at least get an idea of what they look like. MSO S already has an outside bar, regardless of where it closes. The range of this bar is already, uh, pretty much overlapping this entire previous months range pretty much had 1, 2, 3, 6, Red months in a row.

So I'm thinking this is probably ready to move, um, you know, higher over the longer term, you know, we'll see what happens I think today. Oh, is it only up 1.4%? It was up like 5% today. I mean, it was off a tire the day. Sure. Yeah, yeah, yeah, yeah. So, so for me, you know, I'm definitely watching this one for a proxy.

Um, and, and this one may be one that I do enter. Uh, but for now I've got the CGC ACB. I like this one simply because this one just ran, uh, the most last time we had a we'd run. And if you look at today's candle looks pretty similar to this candle. Back in November of 2020, you had, you had your initial spike, you had your pullback and now you've, you, you, we may at least have a, the continuation up the rest of the week.

But another one that I have is a, an active trade for that reason, because it, it can be a pretty high beta mover. Um, any, any names that the chat's wanting to look at today or anything popular on, on that side? Um, well, we do have a question from board to be free asking if you can just show us, uh, the Strat and trend spider, I'm not sure on what specific, um, chart, but so yeah, we do have the Strat, so I'm not sure what part of the Strat on the platform, but the one thing that we do have is the strap where you can pretty much label each.

Uh, each candle as a one to a two up two down or three. And so if you do that, you can see that here and you can scan for these different types of things. Uh, you can change the colors, like if you want a two up to be green and a two down to be red, uh, you know, just right click, go to properties and you can easily change those different colors.

So if we wanted to, up to be green, just change it to green, to down. If we wanted that to be red, just change that to red, and then you'll see those, those do change. So the strata is something that we do have on the platform, both on the visual side, also on, you know, pattern recognition. Maybe you're wanting to learn how to, um, to see these different patterns kind of train your eye.

So you just go, let's say you want to know what a, a one, two down inside break is. You just click apply here and any time you've got one of those, it will show up on the, on the, uh, the chart. So if, if maybe you're still learning the strap and, uh, you want to just kind of train your eye on what these look like.

The pattern recognition is another way you can do it, the scanner, you can go and scan for something like that. So on the strata, if you wanted to go in and look for, you know, uh, whatever. So let's go just type in the Strat. Maybe we want to scan through the S and P 500 for, uh, current months that are possibly setting up as an outside bar.

I know Sarah Strat, uh, was actually looking for that. Today. So I sent that over to her. So if you want to do an outside bar, it says outside bar bullish the Strat. So if we want to look for monthly outside bars that are currently forming, just click scan in any of these bullish outside bars that are currently forming for November, we'll we'll show up.

So that's the nice thing about the scanner is you can scan for something that, uh, has not actually closed yet. And that's a big part of the Strat, right? It's called being enforced, meaning the candle hasn't closed yet. And so that's something that you can use on the scanner, um, when you are using the strap on transpire.

So hopefully that helped. I'm not sure if there was a particular name, they wanted to see the Strat on, but that's how you can. I think he just wants to see, see the studies. So, so that was helpful. We do have some stickers flying on the chat here, uh, babababa. Okay. I'll go to unilaterally. Cause you were specific, he asked for TTCs but the weekly specifically, or he, or she, sorry, I don't know who you are.

Laterally DCF. The weekly. All right. Well, you know, it's, it's a little hard to look at the weekly right now. Cause it's only Monday, you know, halfway through Monday we still have four and a half trading days left in the week. But for now you've just kind of got this inside bar forming. Uh, for me, I'd probably just look at the daily because that's where, that's where we have a little more, uh, We're about to close in a couple hours on the market.

So I'd be looking at this. You do have an inside bar here. You do have a higher lows. So that's something to also keep in mind. But, uh, for now, you know, this thing, this thing is definitely, uh, getting, getting hit over the line a lot over the last, uh, two months or so. And I have no idea what this company does or if it's gotten a catalyst or anything, but at least, I guess you, you're not a fan of the tattoo.

CIF, not, I don't even know what that is. What is it like beyond meat? No, the product, the product, not the stock. No, neither. You're not going to like, then you're not going to like tattoo CIF. Okay. So maybe let's see. I can turn on earnings here. Okay. I guess their earnings are coming up in a week and a half or so.

So I'm assuming this probably got hit because of BYU and D um, earnings. So I'm just curious what they're at right now. Okay. So they, they they'd come back a little bit. Um, but they're still having some trouble here, but, um, yeah, if, if w you know, one thing always with. If you have earnings coming up, it is really hard to use charts as setups what you want to use charts for our upside and downside levels to watch.

So, you know, if you do want to know quickly, if earnings is coming up, just go to other data on transplanter and go to earnings here. So once you click that box, you'll see here that these little, uh, orange vertical lines will show you when earnings were. So here, you know, last week was earnings for BYU and D for CTCF.

Uh, you can see that that orange line is over here for the 26. And I think we get that data from you guys. So that's, that's data provided by Benzinga. Um, and you'll see here that, uh, you know, I would probably wait until after earnings, before I even looked at this, but you know, who knows it, it could maybe move up into earnings with people speculating, but definitely seems like it got hit a little bit from that BYU.

And I, I should clarify. It's not quite the sanding is beyond me, but it is like, like healthy alternatives. Like they have like cauliflower pizza and that sort of thing, you know, like tattooed chef. I won't say that I I've had the cauliflower Mac and cheese, and that was pretty damn good, but yeah, it's a lot of like vegan and vegetarian frozen foods is what it is.

So that's what I meant when I said beyond me. Cause it's similar vegan alternative. Probably at the point, you get the point. So sorry. If I offended anyone's taste buds. Um, what about this? Go back to the chat tickers from the chat here. We got a few. What about, um, doc, you want to look at Doximity doc S E to see docs?

Um, yeah. So another one that recently just had earnings pretty much. Hasn't really moved much from that earnings date, but we're kind of in this weird setup here on, on docs now, correct me if I'm wrong, it looks like this is a recent IPO. Uh, which, yeah, which for me is something like, was it an IPO or a spec?

Never remember demonstrate. I think, I think it was an IPO. Yeah. Cause if it was a SPAC, it was probably a 10, there was an IPO. Um, but yeah, I mean, for this one, you don't have a lot of price history, so that's something that I always kind of keep in mind. If we did a kind of draw this descending trend line here, highlight a zone, you will see that we did break out last week.

Maybe we're just doing a retest here from, uh, from the previous breakout point. You know, we could go down even to round the mid 60 sevens before, uh, before this kind of maybe catches a bid, but for now. The weekly candle is just starting. So there's not much we can, we can do, but I like to use the weekly candle just to see what the overall setup is.

In this case, we just broke out of this downward sloping resistance zone. Uh, so that's why I turned it on. But for now, you know, the weekly candle, I wouldn't put too much emphasis on. There's just too many trading days left in the week to do that yet. Uh, but overall you did have the long-term breakout, uh, on or longterm, medium term, whatever you want to call it two and a half months or so, but the daily's not really telling me much at all.

Okay. Sorry, AAJ. Um, blah, blah, blah, blah. Let's go back to the chat here. We got a few minutes left with Jake from transporter, GoPro. Okay. We're going to go pro from Bonzai buck. Hello? Hey. Yeah. That's relative strength today. That's for sure. Yeah. I think they had good earnings or I did see this one. Let's see.

Turn on other data. Yeah. So earnings was, uh, back in early November and it's gone pretty much straight up since then. So yeah, this one looks really good. Uh, this is one that I would turn on the weekly. Not because I want to see what the weekly candle looks like for this week, but just to see, you know, where we are within the trends.

So if you look at the longer term resistance here, We're pretty much right at it today. So that, that would be something to consider. You know, maybe, maybe this brings some breakout buyers in, if, if this does continue to break out, but this is a pretty strong zone and notice, this is why I want to highlight this is why you use zones, right?

So if we just connected this wick to this WIC, we only have, technically, this would be the third time that we tested this area. If we use the zone, we connect this WIC to this wick and extend it and then pull this down. And then all of a sudden look at what we have now, we've got 1, 2, 3, 4 points on the chart before we only had two.

So, and this would be your fifth. So this is why I like to use these zones rather than, and I mean, some people may even pull it back, even this far to highlight that, too. So this is why I like to use zones, just capture so much more price action and then makes this area a lot stronger, um, than if we just used a wick to wick.

And we only had, you know, this would be the third point on the trend line. So, uh, yeah, we're, we're at a pretty crucial area here on GoPro. And if we did continue up, I mean, you know, this is clearly in an up trend over the last year and a half. And, uh, you know, this would, this would definitely be an area to, to break out.

And if that was the case, that's when I turn on kind of the horizontal level mode and this would be my previous zone to watch around 13. Then the next one would be around there 14 or. So, all right, let's talk, let's talk about lucid LCI, D they report earnings. I believed in night. I think I know, I know you just said that it's hard going into earnings, but we got to ask about this one earlier and I didn't, I didn't want to forget about it.

Yeah, yeah, no, for sure. Well, on the, on the, on the daily, you kind of have this breakout a little bit, so, you know, you got a pretty, pretty decent little pendant here that you're trying to break out of. Um, so I think that's probably what a lot of people are seeing right now. So let me just remove these arrows.

I'm getting all these calls for the black Friday sale. Um, phone has been blowing up all morning from our customer, uh, uh, line. So, so this is what I'd be looking at on lucid. I wouldn't even draw this lower trend line. Maybe if you did draw the lower trend line started all the way from like here. And then you can see that we kind of have this zone rather than, um, rather than just that, that trend line, but same thing, you're kind of breaking out here.

This is where I would definitely turn on the raindrop chart. Now, remember we're going into earnings literally today. So you know, this, this can completely invalidate the setup, but for now you do kind of have this pennant breakout. That would be what I'm thinking. A lot of people are looking at. I was, I did a, uh, I did a recording with fatal warrior yesterday.

He was definitely watching this pennant. So I definitely think this is probably making the market a little bit, the fact that it is breaking out. Uh, but the thing is I would definitely turn on the raindrop and just see where, you know, where some of this volume at today. And you can see not a ton of volume kind of volume.

It kind of looks like almost like a, you know, a donut hole or something like a pretty much a circle. That's not a raindrop that I particularly like. I want to see a lot of the volume at the top of the range. The volume is essentially just these squiggly lines on each side, that's showing the volume profile that's where volume has occurred with it within today's range.

So I don't know. I guys know my thoughts on earnings. I wouldn't hold it into earnings just because there's, you know, you've already got, I mean, reveal and look at reveal and how many cars have they sold? Not a lot. And the valuation is insane. I think some of these electric vehicle names are just getting out of control with some of these valuations, but who knows, maybe the market's going to continue, continue to, um, you know, push it up.

But one thing I would definitely mention is the gap above there definitely is still a gap above two around 56. So for the bull case, you know, 56, uh, around 56 fills that gap above. And that was from pre a previous earnings. Uh, crucial is asking about op star, uh, crucial ups T I've started is coming off interning support from a week ago.

Yes. Uh, tomorrow last Tuesday, their earnings were not great. Actually the earnings hasn't headline number was fine, but they reported, uh, actually their earnings were okay. The headline numbers, but, uh, I, I haven't looked too closely into it, but for whatever reason, the stock had it crushed off its report.

So it's mostly been stuck in this little, little range since then, uh, crucial. But that's why you dropped last week. You're asking for a fundamental reason. There it is. Um, uh, you know, well, and a lot of people, you know, they, earnings does not mean anything. It earnings is, is a way for the market to price in what has, what was expected and what wasn't right.

So like if the market's already priced in a lot of what those good earnings were, then the market's going to pull back. Once those actual numbers come out, it's the same reason why, you know, maybe, maybe a company. Lowers their outlook in the future, because then the market isn't pricing that in, into the stock, the next earnings, all of a sudden you beat or you beat the expectations and that helps the stock price.

So I just think there was a lot priced into this already, uh, based on the fact that we did break this previous lows, not looking great. We're breaking down through these from the, uh, swing low and kind of the handoff period here. So I probably wouldn't touch it. It's another one that I would probably let the dust settle.

I generally don't even really look at entering position after earnings, unless you've got at least a week or two for the dust to settle, but yeah, this one's listening. Okay. Okay. Uh, Georgia skew is asking about Nokia, like a Nokia for a long time. How is an okay doing? Oh, is it doing very look Nokia chart?

That's because that's because it trades over in Europe as well, and that's the primary market. So even though we're trades on the nicey and the U S uh, the primary market, I believe is London, I want to say. Uh, and so it'll just do whatever happens over there. So that's why you get these overnight gaps.

Yeah, it looks, it looks kind of like a gold ETF or something. Um, but yeah, uh, Nokia, I mean, you've got this kind of abandoned baby. Yeah. Forming here, but the problem is is you, you know, that's, that's just what this, uh, set up. I love it. I will be abandoned baby set up. I would never abandoned Cuba. That's not what I'm saying.

Um, but yeah, I mean it, what time is it? It's like, you know, two and a half hours left in the market, so this could easily change, but you do have a little bit of a, uh, that type of setup forming. This is like a meme stock, right? I mean, this, this had kind of it's, it was briefly not anymore. I don't think, I don't really know why this thing called the bait back in.

What does that January? I'm not quite sure I had this similar idea of just like a oh, with Blackberry. Is that what it was? Well, Blackberry and game, you know, just companies that have been kind of defunct over time and had so much, so everyone's favorite technology company from 2003, trying to somehow bring blockbuster stuff.

Got it, got it. Got it. Okay. Yeah. So I mean, the long-term trend is up. Um, if you want to kind of gauge that from around November, 2020, uh, now the thing is you do have the support zone, Wade blow down here in the five twenties. So who knows maybe, you know, maybe it gets there. You do have this huge gap, I guess.

Let's see if that was from earnings. Yeah. This was an earnings gap back in April. So earnings just happened, uh, Last week of October. I don't know for me it's, it's not really, at least like, so there's, there's ways to look at the trend, right? The longer-term trend. We have these higher lows, the shorter term trend here.

We're pretty much just kind of chopping around. I mean, if you look at the range here, we can pretty much draw it in a box. So it's not really doing a lot right now. So for me, it wouldn't, I probably wouldn't really gauge my interest, but who knows, maybe, maybe we get to move up. Um, but yeah, it's, it's stuck right now.

Okay. We'll do one more. One more. Uh, let me just check if this is what I'm thinking of. Yes, no it wasn't but okay. P R O G Progenity I've heard this. I wasn't sure if that was progressive, but it's not. It's a PGR. Um, P R O G I don't, I don't know about pro G, but maybe Jake has thoughts on the chart. I'm not sure.

See, volume is volume. Yeah. It's all over the place. Um, yeah, I've seen, I've seen a lot of people talk about this one. I think it's relatively low, low market cap. I'm not sure, honestly, but yeah, today it's having a good day, but if you, if you look just at the basic trend, we're still kind of in this, uh, area where we've got a short-term downward sloping, lower highs, but I would definitely want to see a close above around three 80 for this thing to really.

Maybe test these previous highs around four and then four 40. And that's simply just literally taking these previous highs and extending a trend line over nothing fancy. Hey guys, Jake would, Jasick joins us every single Monday. And, uh, by the way, if you want trend spider, check it out. We have our own, we have our own offer code.

The offer code is on this. I would say we do have the black Friday sale going on today. It's 65% off. So that is going to be the biggest deal. Um, I'm not sure if you guys have the link to share, but you can also just go to transpire.com 65% off today. We do have a sale going on until, uh, I think cyber Monday.

So what it does is it drops every day. So it's 65 today. It's 64 tomorrow 63 the next day. So this is definitely going to be the highest, uh, discount percentage that we have. I was going to say the lowest price kind of, that you'll be able to do, uh, for today. So definitely check it out. We, you know, we, we definitely want you to be able to try it out first.

So if you do even start your free trial today, you'll be locked into that 65% off. So, you know, don't think I can't do my free trial. I have to lock in the 65%. You can start the free trial today and you'll be grandfathered in for a week when you have that seven day. Damn. All right, Jay, who? Jazz stick. He joins every Monday.

I talking shards, talking, raindrops, talking, throwing babies out with the bath water or something like that. Uh, Jake, I appreciate your time as always, sir, have a good one. All right. Uh, Arab ready before we bring on our last guest of the day, um, as something sad to report. And that is that after six years, my ID badge holder to gain to the building is finally broken.

Oh wow. And I need to get a new one. Well, that might, it might take about six to eight months considering the supply chain issues to get a new, uh, this is my ID badge. The holder is broke and attaches to my belt clip. It is broken and I don't know what to do. Uh, here, you guys want to see what my, what my ID badge picture was from six years ago.

I don't know if you could zoom in on that, uh, Rowan, but, um, it broke just now and it's very sad. So anyway, uh, what are we at on the lakefront guys? Not enough. Can we get to 400 likes today? Uh, we'll make it 300. Well, we'll make the goal of 300. Can we get to 300 likes? I don't know. We should try. Um, what else did I write down?

I want to make sure we didn't forget things. There was one more. Okay. There's one more stock that we're asked to have before we were asked to by DM, we'll ask our next guest about that. Chris Capri. I'm seeing some headlines that, uh, Powell. Being reinstated was once seen as a layup. And now it's like 50, 50.

Yeah. The betting markets are, uh, unsure. Sure. Coin flip on uncle J. Yep. About uncle Jay is, would be replacement is a lady by the name of Lael. I'm going to mess up her last while. Maybe wait. Well wait, all Bernard. Yeah. She's she? She's a fed president. Yeah. Yeah. Okay. So she potentially may replace pal, but it seems like they have pretty similar stances on those things.

I just don't know how the markets would react. So Powell being, getting the boot. All right. Let's bring Chris on Chris. Capri Shelley says release. Chris. Chris is here. Chris Capri. There is release the hounds. I don't know if she, I don't know which Chris she's referring to. There's more than one, but this is the Chris.

We have so deal with it. What's up. What's up, man? How are we doing? How are we doing today? Uh, I showed him my dad a segment that you were on with me a couple of weeks ago. And he said, Hey, that Chris guy, I know he seems to know a lot. And my dad's a hard guy, a hard man to please. I would know. So, uh, you got the endorsement from Mr.

Israel. Uh, I appreciate that. I am playing a sad violin song right now for your badge being broken. So yeah, it's very sad. Yeah. Anyway, just before we get started with some charts. Well, tell us about your, your new role. I saw you had a nice, what is this breaking news, Chris Capri and Benzinga yes. I'm, uh, writing some content for y'all right now.

And, uh, you know, according to Luke, we're in a trial phase, so we might, uh, we might make this go full, you know, like, uh, a more, um, how could you say a full on approach? So yeah, I'm writing option content right now. Uh, I'm not sure how many option writers you have, but, um, yeah, I'm writing a content similar to the ones that I do on the live show basically.

Got it. So essentially like written form content of what we discussed on the show and we're looking at, uh, option data of certain stocks, assets, et cetera. Um, so yeah, so anyone watching stay on the lookout for some nice articles coming out about by Chris this week? I bet you, I could find the link. Do we re order, right.

A couple of. Oh, yeah, many. So you need the QD. We did a, we covered, um, there was, uh, institutional trades at a pretty large option bet on LTD. So we covered that. Um, the one thing that this is the article page in the chat right there. I thinking that column slash author slash Chris dash Capri right there in chat, we've got a metal platforms we got, oh, the I shares bond DTF, interesting door dash open door.

Is the door open for open door? So fi affirm. He said all the sexy names. Yep. The only thing is they don't get the flexibility that I do on this show to actually call it live trade outs because, but that's, you know, just part of the regulations and I get that. So, so yeah, so I can't, you know, give quite the same trade recommendations, but some of the core analysis is still in there and it's obviously, you know, this is coverage every day.

So this is I'm here for the best Chris Capri content. But if you want a little bit of extra, then you can go to his author profile on benzinga.com. All right, Chris, without further ado, what do you got on the docket for us today? Trade desk. So let's start with trade desk. Um, let's get it grown. Yeah, my bad dog.

Yeah, till TD.

So, um, we broke all time highs and just this last week on a earnings, very strong volume and close above it and just straight buying from the open, fair, very strong to start. So we feel like this area is going to between 95 and a hundred is going to hold on pullbacks. And so I'm looking to get long on pullbacks, the way I'm probably gonna play it is I will wait for a little bit more of, um, an aggressive dip.

Let those puts kind of charge in value. So as the market falls puts increase in value and so let them charge a bit and then I'll either buy because I am happy to be long, the stock between 100 and say 98 and a quarter. So I will sell the cash secure puts on this for this weekly OPEX. And so I'll wait, you know, if we can get a dip down to say one to three or one or two, then I'll probably sell the hundreds or the 90 nines.

Um, but probably the hundreds sell the cash secure puts. It basically means that if we close below a hundred by this Friday is expiring and those puts get exercised. I'll be long at a hundred, which is where I want to be. So I prefer this as an entry to. That if there's a price, I want to get long at a particular price, instead of just waiting for price to get down there, I might as well get paid to wait for that.

So I'm totally happy to be along at a hundred, so I will sell the cash secure, puts, get a little bit of a ditch charges puts up and then I'll sell them for this Friday. So that's the first one on the list. Okay. We have a setup here in TTD. What else we got? Uh, just checking comments. It seems like we're all good.

So CrowdStrike, CrowdStrike. And let me pull up the one minute. I want to start off with the weekly and then we'll go to the one minute real quick on this one here. So CrowdStrike has, you know, kind of form this I'm missing my wonderful pen. One second. Loading up the trusty pen. There she is. Okay. So CrowdStrike has kind of created this balance zone, minor false break.

When it broke above it, it treated this as the base for its launching pad higher. We've now kind of formed another correct structure. And when I look at the options kind of open interest and everything like that, I feel like two 40 to two 30 is a solid area to get long. So I'm running the same playbook on this one.

As I am TDD, I'm selling cash secure puts between two 40 and two 30. The trigger for me today as I was watching this in real time on the live chart was let's go to one minute. So sold off, which is nice. That's what we want. That charges, the puts, um, we had this kind of, we hit this two 50 right here. There we go.

So we hit two 50 right here and volume. If you look at it, leading into this falling is pretty flat while we're selling off aggressively, we hit two 50, we get a big spike and we get a big volume spike on the woman. Just to be clear, this is from this morning, right? This is this morning, then, uh, you know, we get a few more volume spikes and the volumes a little bit different.

So we get a little bit of a pop. Now we're kind of, you know, floating back a little bit, but if you notice, let me stretch the screen a little bit here. Do you see how we're kind of, kind of chopping around this two 50 area and showing that, Hey, there's some liquidity there, some interest here, anytime you see something that's been aggressively selling off and then it's not selling off so much.

This right here is a transition. All these prior kind of moves. If I show you an extended out, everything produced a lower, low, so base lower, low, lower, low, lower, low, low, low. So here's the two 50 where he had that volume spike. We did produce a lower, low and produce a lower high another little over, but now look, what's happening here instead of just making a new low, we tag this low and now we're starting a base that suggests to me that possibly that the open interest.

It's strong and that dealers might be no longer trading with the market, but trading into the market. So trading with the market is the situation where if the stock sells off, the dealers have to sell that stock to adjust their hedges basically, and trading into the market is as the stock starts to sell off, the dealers actually have to buy into that, sell off.

So the trading into the market, not with the market. And I'm sensing that as two 50 spike was kind of like that first shot across the bow saying like, Hey, we're going to start doing some hedging at this area. And the fact that we've gotten a little bit, you know, kind of a consolidation and a decent pushup here, I think if we close above 2 51 or 2 54, then that will suggest the open interest is strong net.

How, how would you know though, just by looking at the chart that, um, uh, the, uh, market-makers are, uh, would have to trade with or against the market, you wouldn't, you wouldn't know, um, in and of the chart itself, it would be if you have access to option data and flows, if you can get pretty good at reading open interests and understand how gamma rate of change changes based upon the various strikes are at, then it would be much easier to see what's happening.

But let's say you don't have access to data because most traders don't have access to that data. Well, then what you'd want to see is. Generally around a major strike, you know, and even number 2 50, 2 49, 2 45, $5 numbers, $10 numbers, kind of thing like that. But you need to see a transition. You need to see a transition and the transition would manifest itself in the price section and saying like, look, what was the structure before this?

Prior to this bounce off of two 50, everything was pretty much hammering below the nine and the 20 with very mild pullbacks, again, lower highs, lower lows, but now we're seeing a transition and that transition around a major strike. If you didn't know, would kind of be, Hey, there might be something here without the access to the flow data.

It's a very hard, so you just have to rely upon transitions. Okay. If the market is selling off so aggressively, and this is strong, I mean, this is a very strong drop in CrowdStrike. You know, it opens right around two 70, we dropped $20. That's almost a 10% move. It's like 15%, 18% roughly. And then all of a sudden you start to see a transition.

Why would it, why would it all of a sudden stop on the day? Yeah, you could say it's oversold, but generally that's because it runs into order flow there that creates a transition it's too strong and it's going to start kind of pushing against that. Okay. Whether it's market dynamic, plumbing, dynamics, or technical, whatever, all that really matters though.

Is your point about the stocks forming, forming a base here? Yes. You would need to see, you'd want to see a transition Instructure. So if everything's making lower highs, lower Oslo, highs, lows, and then all of a sudden, you know, that Laura has lowers all of a sudden go sideways. That's a transition. Now that transition doesn't mean reversal, but it does mean that, Hey, we are, we were selling aggressively.

We no longer are. That is oftentimes, you know, the first kind of change in the system of saying like, Hey, the order flow has changed at least for this balance or rebalancing structure. And so this would be the first sign. Now, if we start to take out these highs and these highs, that's the second transition in place.

So the more transitions you have in place, the, the greater, the chance that a reversal, you know, is happening. And that could be because of dealer order flows, large institutional buyers coming in. It doesn't really matter, but those transitions, the more that they start to stack up, the more the evidence starts to shift to, Hey, we've hit a zone where it's just not going past it.

And now it's.

Um, a question from Shelley here in the, uh, in the chat, is it better to use one minute charts with options because that's what you've got up right now? No, um, it just depends on, um, what kind of trading you're doing if you're day trading options. Yeah. Woman in five minutes. Fantastic. Um, but if you're not day trading options, I generally don't recommend, um, you know, trading off the one minute chart.

It would depend upon what your holding times are. So if you're holding for, you know, one week, two week, three weeks out, the one minute is only gonna help you. If you're really trying to time the pricing of the options to perfection, you know, if you're really trying to find that optimal time to, okay, Hey look, I'm going to sell a calf secure boots.

The market's selling off. I need to time this as close to the bottom as possible because as this market sells off like this, those puts are going up in value. Once the market starts to transition sideways or go up, these puts start to go down in value. So if you're looking for the absolute best pricing and you're holding these options for a few days, maybe a week, okay, sure.

You can start to look at these lower timeframes, but if the pricing isn't so much of an issue, then you don't really need to look at the one minute chart. So it really depends on your holding times and how you're trying to work with. Does that make sense? It does. So the takeaway here is that, I mean, do you have a, do you have an actual trade for us in crash drag?

Or are you pointing, are you pointing this out more to say, Hey, here's a potential change in direction by art, but let's bring yourself into set up here. Yeah. We sold the cash for two 40 secure puts this morning. Oh, okay. Once we had this little bounce, we sold it. We tied, we gave it to our members right away, posted in our, a live trade channel and said, Hey, we're short.

Or we sold these right now, two 40 for the, this expire right now. They're actually slightly priced a little bit better right now. So if you felt like you could do that, I'd recommend it. Keep in mind when you sell cash secure boots, you do have to have a decent amount of margin depending on the price of the stock.

And, uh, you generally, you don't sell these unless one of two conditions is really in case in place one, you actually want to get long, the stock, wherever you're strike. We sold the two 40. I want to be long in 40. I'm totally comfortable being willing to 40, even if we close below it, I'm totally along with being comfortable at two 40.

The other situation would be, you don't think the more you think it's a low probability that the market's going to get below the strike that you're selling the cash secure puts. And you're really there just to collect the premium. If you're there to collect the premium and you think it's a low probability, then I would do it.

Just keep in mind, puts when they sell off, they gain in value faster than calls gain in value. So it's super important that you understand that, that if you're not willing to be long at that price, you're going to be a lot more sensitive to price changes, especially if that stock falls. Awesome. Awesome.

All right. So now we have the logic behind the trade and we have the actual trade itself. And then do we have a target? I mean, I guess two 40 would mean, uh, so I don't have a target. Did you say, did you say the exploration on these? I don't remember this Friday, this Friday, this Friday. So, and let me kind of, you know, dive into a little bit more of why I want to be long at two 40.

So if you look at two 40 let's, let's move this line up here to there's two 40. You can see this as a pretty rich zone of support. There's a lot of order flow here. And we haven't, since, you know, when is this? Since June of this year, we've only had one weekly close inside. This everything's been above it.

The market has rejected this kind of two 40 to two 30 zone since June. So I believe that we'll hold. And I like CrowdStrike as a type of stock that I would like to hold for a few months at a time. So this is what I would classify as a medium term swing trade. But instead of just putting a limit order to buy the stock, why not get paid to wait and see if we can get in at that same limit or that's why it's nice to get paid while, while waiting.

I mean, think of how many limit orders you placed on a stock over the years. And imagine if every single one of those, instead of just putting the limit order, you don't get paid or anything like that. Imagine if you had sold premium to get into that order every single time. Imagine if we collected one to $3 in premium, every single limit order that all adds up.

That's a great idea. That's a good idea. All right. We got about 12 minutes left here. Chris, what other stocks trays on your radar here? And then we can go to stuff from the IWM and then, uh, let's do chat. So, alright. I Nerium small caps had a very important structural breakout. It's been inside of this.

What is this range? This is a weekly it's been inside this range for quite a long time, you know, impressive run in February 21. That's when everything was just screaming and then everything pulled back and IWMS instead of kind of like the S and P 500 or the QS making kind of like some lower lows short term, they just kind of stuck it and held this corrective structure for a while.

So IWMS has been stuck between 2 30, 4 and two 11. You know, since February, this year, two weeks ago breaks out. And, you know, we had kind of told our members, look, it's not getting above 2 45 this week. It didn't, it's pull back since then. We like getting long IWMS, you know, between 2 34 and say two 30. So again, it's the same play.

I feel like instead of getting long options, you know, won gamma, which we could, you could trade, you could trade this either way. I'm going to sell the cash secured puts. Cause I want to be long IWMS between 2 34 and two 30. So I will be happy to sell them for the. Ideally, it closes below that it gets exercise I'm long and then I'll sell weekly premium.

The plan is to hold IWMS through the December OPEX, which is the 17th. The monthly OPEX is the 17th. And I believe that between, you know, the end of this week and December OPEX, we will get to 2 45, maybe even push past that. Now let's say you don't want to sell cashier puts, or maybe it's too much of a margin.

Fine. Then I would say, wait until we break this week low here, which is around 2 30, 6 and a half. If we do that, the calls will be really cheap. And so you could get long calls that for the December monthly OPEX, by the two 30 fours, you could do that, but you may have a little bit of time to gain, or you can buy a bull call spread.

That would mean getting long, the 2 34 calls here and selling the two 40 fives here. So I would think either you get long calls, if you just want to be long out where I calls or you sell the bull call spread, that would be my recommendation. I believe IWM comes back into the zone, holds his zone, and then it makes another attack up to 2 45 before the end of the year.

So that's the plan. Yeah, that, that big, that big old breakout keynote from two weeks ago, sorta changed everyone's perception here. Right? Cause we were just waiting. We were waiting and waiting and waiting for all the, almost the entire year for something to happen and then they, and then it happened, but now we're, now, now you're playing the pullback, which I guess is smart.

So it's to be expected, we kind of ran into some hedging. So this was kind of that same situation where dealers were in a situation where once we start getting into 2 45, they actually had to trade into the market. So the market's rising and they had to actually start selling as we got to 2 45 and we just couldn't get past it, you know, try and try boom, big sell off.

So, you know, 2 45 was really, you know, we told our members every single day, like it's not getting past 2 45, it's not getting past 2 45. There's just too much open interest. And there's too much kind of hedging requirements for them that they will start selling as we get into that. And so that's what's happened and this pullback has kind of been expected.

It's taken two weeks, which is fine with me. I think this is probably the last week of the pullback at best. We have one more week of a pullback. And then I think after that, we start to, you know, take off. I wouldn't be surprised to see IWMS take kind of a little, you know, another aggressive turn to the upside.

This is the monthly op ex this Friday. So the options board will reset. There's a decent amount of positive gamma and IWMS. Positive gamma is important because it means that the market is net long options. And so that means that the market is it's not only net long options. There are net long calls right now.

So the market's net long options. This pullback is definitely less aggressive than the buy-up, which means that the sellers don't have as much force as the buyers did on the way up. And so I think the buyers will step in and then make that attack there. All right. Should we go to the chat? AB are you awake?

I'm awake. I just checking on you, man. I don't know. You're awfully quiet over there. Um, we have some takers here from the chat I want to, I want to ask about, uh, and Duardo asked about snowflake. Like we talk about snow, like every single week on this shit I own in my longterm portfolio. Um, it's hard not to like snow right now.

It's just such a gangster stock. So let me take a look at the options flows on the gangster stocks you hear that I never heard of long. So we have a long-term investing service on and snow is one of our picks. And so it's, you know, it's performing incredibly well right now. All right. So snow, even though it's a pretty, I mean, it's an impressive stock.

You're talking. If it closes bullets this week, it's another seven weeks up, which is amazing. It does have earnings coming up. But with that being said, snow for such a big stock, actually doesn't have a whole lot of options, a decent amount of options. This is about 110,000 calls and there's 119,000 puts in the market.

I wouldn't have guessed the top. You know, there, there could be a lot of reasons, but you know, it, it doesn't quite have the same. How could I say it? It has a quite broad base attention. You know, this is a stock that's only come around alive about a year ago from today. So a year and two months ago. So it still hasn't hit the broad investment in community.

I'm willing to bet someone who doesn't like watch Benzinga regular doesn't trade actively. They probably don't know a whole lot about snowflakes. So it's not like a name that's really permeated. You ask somebody, who's like a Robin hood investor who doesn't like, look at the markets much. You got some on Amazon, Microsoft.

They know that you say snowflake, they'll be like, what? So it's not something that's really penetrated into everybody's minds. It's not, it's not a household name and it's not necessarily a software or product that everybody uses. You know, this is something that's for corporations, basically. So with that being said, snowflake has about 32% of the options rolling off this Friday.

And that's going to create a little bit of a headwind as we go forward. So. I don't really see snowflake because of that headwind because of all the options rolling off and we're heading into resistance. I don't see it getting past this resistance, you know, this week. I think we get a little bit of a pullback in that.

Where do I think there's going to be resistance? I think we start getting into strong resistance around 400, 404 0 5, 4 10. I think it at best it hits four 10, and then it pulls back this week. Where would I want to get long snow based upon option flows. We'll just take a look at something real quick

while Chris is doing that. Let's get that light counter up. Everyone let's get up to over 200. I think that's easily doable. So looking at, because it's not a heavy option stock, you generally don't have to worry about the entire week. Not you have to worry about the monthly expires the one week expirees don't have as much value unless we have an earnings, which we do coming up on the first year.

That's next Thursday. I think so. Yeah. So I'm looking nothing crazy on the December 3rd, expiring, nothing crazy on the 26. So let's look out to the December expiring. Yeah. I keep seeing solid open interests. 3 53 63 70, the strongest open interest right now for the December. Expiry is. And so I could see it pinning 404, 10, 4 20 by December OPEX.

But I think we get a little bit of a pullback. I would probably look at the monthly view operate here because that's where I see some decent strikes, three 70 there's some at 360 and then three 50 or some really good strikes. So I think this probably presses towards, you know, Tuesday, Wednesday, Thursday, Thursday, Friday, the options start to roll off.

This starts to get a little bit of a pullback. If we can get a pull back to three 70, I think it's a decent opportunity to get long. Yeah. I liked that area there. Oh, all right. So hope you're happy. Who asked about that? Uh, Eduardo. I hope you're happy. Okay. Um, I don't know if, if, if I can ask Chris, my GDPR, it's the high fly short squeeze back of the day.

I don't know if do we even have options. So we actually do. It's not gangster we have about, this is what I would call mild. In terms of options volume, you got about 200, 7,000 calls you only got about 50,000, puts anything below 500,000 is what I call mild flows above five, 500,000. You got about medium flows.

Once you're at a million, the data is really robust at that point with that being said, GPI. Okay. So. Prior to today, 250,000 options on GPI. How many options where trade today? 327,000. That is rare to see the single day option flows, outpace the total options in the universe. Prior to that day, we're at like 140, 150% of the total options in the universe.

So let's dive into the just happened today. Just happened today. I have so crumbles. Yeah. Now keep in mind. This is, this is not a stock with weekly options. So today, alone here, I'll just pull out the detached screen. So you guys can look through this real time. Let me show you. Okay. So here's your total options on the day 290,000 calls?

36,000 puts. That basically means that you're taking like nine out of 10 options are basically calls right now. And so where is the volume all concentrated right there. Now I haven't looked at what's. The price are now 1542. Yeah. It's struggling here. So prior to today I would have felt like it was good support at $10.

Yeah, it was good support at $10 and 21% of the options were rolling on. This Friday, but you add all these options. This is like 55. It's 80,000. Now we're at a hundred thousand, you got 125,000 calls that are expiring this Friday. And so if this doesn't rip further, then those calls are going to start to get monetized because they're going to start to lose state of decay in value pretty fast.

The 17 and a halfs are priced at a dollar five bid. They're going to lose 22 cents just by holding this overnight. So hold it overnight. Now that thing's worth 80 cents, roughly. So these long calls are going to start to get monetized pretty soon. And so what's, is there a question, if somebody wondering if it's going to hit a certain target, which the eight-year crazy stock of the day?

I don't know what they're asking and everyone's asking about this is, I don't know, guys, this is, this is a trade for today. Yeah. Let me take a look at, uh, let me put it up real quick. I don't know if CPI, like in four days, we're not, we're not going to remember what this stock was. So, um, no unlikely, unlikely, because you don't have a weekly OPEX.

And so you're talking, you're talking 140,000 of these 328,000 options are going to roll off the Friday and every day that this thing doesn't gain more ground. Like if it doesn't make it past the weekly high today, those calls are just going to close them out for whatever value they have. So I feel like.

Because it kind of goes past the data we have and we just stretched a bunch of calls. I would say your absolute top for the week based on this is 22 and a half. And I seriously doubt we're going to get that. I seriously doubt. We're going to get that. There's a lot of volume there, not much open interest, even that the twenties are kind of looking more like, Hey, this is about as far as it gets.

So and that's, and it's going to need a new push because if it doesn't option decay is going to be pretty fast. And a lot of those people that are watching calls are gonna be like, Hey, I want to be out with whatever I can capture. I don't want to hold this till Friday. Yeah, I think it's drugs. Alright, Chris, Capri, he run second sky's trading and go to second sky's forex.com it redirects to his site, or go to benzinga.com and I'll put the link up on the screen again.

benzinga.com/author/chris-capri and canvas Saturday. I will be teaching as well. I'll be teaching. I think the bootcamp. Yes. I think, I think I'm covering on trends. I think that's what we're going to be crafted look, but I think we'll be talking about. Benzinga bootcamp.com all day nine to five all day trading education, tactical analysis, a whole lot more.

Chris will be there. You'll be there. I'll be there. He'll be there. If we can drag him out of bed at that hour, Chris, have a good woman. We'll see you on Saturday. Have a good rest of your week. Good seeing you take care. All right. Talk soon, Chris. All right. AB you were disturbingly quiet today. I hope you're okay.

Oh, I'm great. Okay. I hope I hope your portfolio is it was okay. Doing well. Looking at some trades, trying to get, you know, get myself Turner red bay green. You know how it goes? Um, all right, Spencer, we've got moon or bus coming up right now. Our guys, Ryan McNamara and Logan Ross, we'll be taking you through the wild world of crypto.

Um, so without further ado, let's go ahead and wrap the show and get over to Mooner bus. Please smash the, like if you have not already, and as always shoot us an [email protected] with any feedback, questions, comments, concerns, et cetera. With that, we will leave y'all to the crypto guys and see you all tomorrow at noon Eastern.

Did you know, nearly all stock price changes of 10% or more result from a single news headline. That's right. News headlines have a unique ability to drive stock prices up or down. These news catalysts create trading opportunities every day. All you need is a little help to reach out and take them. And if you're looking to grow your portfolio, it doesn't matter if your investment budget is small or big and easy to read.

Stream of news. Headlines will increase your opportunities to profit from price changes in the stock market, consolidate a knowledge-based investment strategy and grow your portfolio. All you need is Benzinga pro and it's powerful news alerts, price tracking, and portfolio monitoring. To make a positive change in your trading performance.

We've already helped thousands of retail traders across the world, and they could not be happier. Increase your market knowledge, boost your exposure to big movers and make informed trades before major price changes. The opportunities are all around you. Subscribe now and will skyrocket your portfolio today.

Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-content

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy